Boston - Just as the trend in psoriasis treatment veers toward more systemic modalities with the biologic revolution, a new topical treatment with low toxicity may provide solutions for patients who have not responded to conventional therapy.
Addressing Disparities in Skin-Aging Prevention Among Women of Color
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Upadacitinib Outperforms Dupilumab in Primary and Secondary End Points in Head-to-Head AD Study
ReV Up Your Vitiligo Treatment Strategies
Seemal Desai, MD, Responds to Study Suggesting Melanoma is Overdiagnosed in White Patients
Federal Trade Commission Votes to Ban Noncompete Clauses Between Employers and Workers